Oncolyze, Inc.
PrivateLast Round
Series A
Aug 4, 2022
Est. Valuation
$30M
Total Funding Raised
$300,000
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Oncolyze, Inc. operates in Healthcare & Life Sciences and is based in New York City, New York. Its latest recorded funding round was a Series A round in August 2022.
Oncolyze, Inc. is a biotechnology company developing novel biotherapeutics for the treatment of cancer.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Oncolyze, Inc. Comparables
Compare Oncolyze, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| A28 Therapeutics | 79% | |
| Peptomyc | 78% | |
| Lytix Biopharma AS | 73% |
For institutional investors. Book with your work email.
Oncolyze, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Aug 4, 2022 | ||||
| Seed | Jan 1, 2019 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Oncolyze, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| The Naissos Group | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 24, 2026
Monthly visitors grew 501% MoM.
- Apr 16, 2026
Monthly visitors increased 113% MoM.
For institutional investors. Book with your work email.
Oncolyze, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Oncolyze, Inc.'s valuation, stock price, and market status.
Is Oncolyze, Inc. a public or private company?
Oncolyze, Inc. is a private company.
What is the current stock price of Oncolyze, Inc.?
Oncolyze, Inc. is a private company, so its shares have no public market price. Caplight tracks Oncolyze, Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Oncolyze, Inc. worth (valuation)?
Oncolyze, Inc.'s valuation is estimated at $30.0M based on funding round data.
Can I buy Oncolyze, Inc. stock?
Oncolyze, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Oncolyze, Inc.'s last funding round?
Oncolyze, Inc.'s most recent funding round was Series A on August 4, 2022.
Who are the main investors in Oncolyze, Inc.?
Key investors in Oncolyze, Inc. include The Naissos Group.
Will Oncolyze, Inc. IPO soon?
No public IPO plans have been announced for Oncolyze, Inc..
How can I track Oncolyze, Inc. secondary market activity?
Caplight tracks bids, offers, and trades in Oncolyze, Inc.'s shares on secondary markets.